Karmanos Cancer Insitute — Detroit, Michigan

Karmanos Cancer Insitute is a clinical research site located in Detroit, Michigan, United States 48201.

Crixeo Health Trust Score: 68/100 (FAIR). This profile has not yet been claimed by the site owner.

Karmanos Cancer Insitute has participated in 4 clinical trials with 3 currently active.

Therapeutic areas: Non-Small Cell Lung Cancer, Monoclonal Gammopathy, Smoldering Multiple Myeloma.

Sponsors: Summit Therapeutics, Dana-Farber Cancer Institute, Adaptimmune.

Sponsor Feasibility Report

Trust Score: 68/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Karmanos Cancer Insitute?

Karmanos Cancer Insitute has a Crixeo Trust Score of 68/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Karmanos Cancer Insitute conducted?

Karmanos Cancer Insitute has 4 clinical trials on record, with 3 currently active. Their work covers Non-Small Cell Lung Cancer, Monoclonal Gammopathy, Smoldering Multiple Myeloma.

Is Karmanos Cancer Insitute accredited by Crixeo Health?

Karmanos Cancer Insitute has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Karmanos Cancer Insitute?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.